Fundraising Fox

Verax Biomedical

Marlborough, US · 1 known investors

veraxbiomedical.com ↗

Verax Biomedical develops PGDprime, a bacterial detection system for blood platelet screening that meets FDA guidance on bacterial risk control. The product is designed for blood collection establishments to enhance pathogen detection while enabling extended product shelf life.

BiotechHealthtechMedical Devices

Founders & leadership

JK
JAMES KOZIARZDirector
JR
JOE R. SANDERSExecutive Officer, Director
RZ
ROBERT ZIESERLDirector
BB
BUZZ BENSONDirector
YR
YLI REMO VALLEJOExecutive Officer
RS
R. SCOTT MCKENZIE, SR.Executive Officer
NA
NANCY A. HORNBAKERExecutive Officer
PR
PAUL RAGUSAExecutive Officer
MG
MARC GOLDBERGDirector
JL
JAMES LOUSARARIANExecutive Officer, Director
JD
JOE DEL GUERCIODirector

Investors · 1

Bioventures InvestorsWestborough · $15M – $100M

Reported raises · per SEC filings

Form D private placements
▶$2.5MraisedSep 2019 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James LousararianExecutive Officer, Director
  • Paul RagusaExecutive Officer
  • Joe SandersDirector
  • Robert FlanaganDirector
  • Marc GoldbergDirector
Offering amount
$10.5M
Amount sold
$2.5M
Sales commissions
$425K
Placement agents
Thomas Frederick Zipser
First sale
Sep 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.4MraisedNov 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES LOUSARARIANExecutive Officer, Director
  • JOE SANDERSExecutive Officer, Director
  • MARC E. GOLDBERGDirector
  • JOE DEL GUERCIODirector
Offering amount
$24.1M
Amount sold
$11.4M
First sale
Oct 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.6MraisedJun 2016 · 64 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • PAUL RAGUSAExecutive Officer
  • MARC E. GOLDBERGDirector
  • JAMES KOZIARZDirector
  • JAMES LOUSARARIANExecutive Officer, Director
  • YLI REMO VALLEJOExecutive Officer
  • JOE DEL GUERCIODirector
  • NANCY A. HORNBAKERExecutive Officer
  • JOE R. SANDERSExecutive Officer, Director
  • R. SCOTT MCKENZIEExecutive Officer
Offering amount
$24.5M
Amount sold
$12.6M
First sale
Feb 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedJan 2015 · 61 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES KOZIARZDirector
  • JOE R. SANDERSExecutive Officer, Director
  • ROBERT ZIESERLDirector
  • BUZZ BENSONDirector
  • YLI REMO VALLEJOExecutive Officer
  • R. SCOTT MCKENZIE, SR.Executive Officer
  • NANCY A. HORNBAKERExecutive Officer
  • PAUL RAGUSAExecutive Officer
  • MARC GOLDBERGDirector
  • JAMES LOUSARARIANExecutive Officer, Director
  • JOE DEL GUERCIODirector
Offering amount
$4M
Amount sold
$4M
First sale
Jan 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.